Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Hereditary breast cancer: clinical features and risk reduction strategies.

Paradiso A, Formenti S.

Ann Oncol. 2011 Jan;22 Suppl 1:i31-6. doi: 10.1093/annonc/mdq663. Review.

PMID:
21285148
2.

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.

Pierce L.

Semin Radiat Oncol. 2002 Oct;12(4):352-61. Review.

PMID:
12382193
3.

Chemoprevention of breast cancer.

Osborne MP.

Surg Clin North Am. 1999 Oct;79(5):1207-21. Review.

PMID:
10572559
4.

Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006.

Liebens FP, Carly B, Pastijn A, Rozenberg S.

Eur J Cancer. 2007 Jan;43(2):238-57. Review.

PMID:
17095205
5.

The prevention of hereditary breast cancer.

Rodriquez E, Domchek SM.

Semin Oncol. 2007 Oct;34(5):401-5. Review.

PMID:
17920894
6.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

7.

Management of the BRCA mutation carrier or high-risk patient.

Bordeleau LJ, Lipa JE, Neligan PC.

Clin Plast Surg. 2007 Jan;34(1):15-27; abstract v. Review.

PMID:
17307068
8.

Can genetic testing guide treatment in breast cancer?

Tutt A, Ashworth A.

Eur J Cancer. 2008 Dec;44(18):2774-80. doi: 10.1016/j.ejca.2008.10.009. Review.

PMID:
19027287
9.

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.

PMID:
11759816
10.

Recognition and management of hereditary breast cancer syndromes.

Thull DL, Vogel VG.

Oncologist. 2004;9(1):13-24. Review.

11.

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Pruthi S, Gostout BS, Lindor NM.

Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Review.

12.

Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.

Metcalfe KA.

Womens Health (Lond). 2009 Jan;5(1):63-8. doi: 10.2217/17455057.5.1.63. Review.

PMID:
19102642
14.

Radiotherapy and genetic predisposition to breast cancer.

Turnbull C, Mirugaesu N, Eeles R.

Clin Oncol (R Coll Radiol). 2006 Apr;18(3):257-67. Review.

PMID:
16605057
15.

Management of women at increased risk for hereditary breast cancer.

Smith KL, Isaacs C.

Breast Dis. 2006-2007;27:51-67. Review.

PMID:
17917140
16.
17.

[Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].

Pujol P, This P, Noruzinia M, Stoppa-Lyonnet D, Maudelonde T.

Bull Cancer. 2004 Jul-Aug;91(7-8):583-91. Review. French.

18.

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.

Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A.

Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Review.

PMID:
20033769
19.

Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.

Bernier J, Poortmans P.

Breast. 2015 Apr;24(2):100-6. doi: 10.1016/j.breast.2014.12.003. Review.

PMID:
25557581
20.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901

Supplemental Content

Support Center